Analyst Ratings for Larimar Therapeutics (LRMR)
LRMR Rating Summary
LRMR Price Target Summary
- Highest: $26.00 (Guggenheim)
- Lowest: $5.00 (Baird)
- Average: $14.36
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.36 (+288.2%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$14.36 (+288.2%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/2/2026 | H.C. Wainwright | Raghuram Selvaraju | New Coverage | Buy (N/A) |
10.00 (N/A) |
3.21 (3.70) |
15.26% | Details |
| 5/27/2026 | JPMorgan | Tessa Romero | New Coverage | Overweight (N/A) |
9.00 (N/A) |
3.45 (3.70) |
7.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
